NCT00654914View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction

PHASE3CompletedINTERVENTIONAL

Enrollment

527

Participants

Timeline

Start Date

May 31, 2003

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Erectile Dysfunction

Interventions

DRUG

Levitra (Vardenafil, BAY38-9456)

10 mg per dose of vardenafil for the first four weeks. A further 8 weeks ( in two treatment periods of four weeks, respectively) where patients will either maintain the previous dosage regimen or will step up to 20 mg per dose of vardenafil or will step down to 5 mg per dose of vardenafil, at interval visits of four weeks .